Huntsman (HUN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
13 Jul, 2026Executive summary
Olin and Huntsman have agreed to a merger of equals, to be executed either as a direct merger (Huntsman merges into Olin) or a subsidiary merger (Huntsman becomes a wholly owned subsidiary of Olin, then merges into another Olin subsidiary).
The merger consideration for Huntsman stockholders is 0.5476 shares of Olin common stock per Huntsman share, with Olin shareholders owning about 54.5% and Huntsman stockholders about 45.5% of the combined company post-merger.
The combined company will be named OlinHuntsman Corporation and will be listed on the NYSE under a new ticker symbol.
The merger is expected to close in the first half of 2027, subject to regulatory and shareholder approvals.
Voting matters and shareholder proposals
Olin shareholders will vote on: (1) the direct merger proposal, (2) the subsidiary merger proposal, (3) an advisory vote on executive compensation related to the merger, and (4) adjournment of the special meeting if needed.
Huntsman stockholders will vote on: (1) the merger proposal, (2) an advisory vote on executive compensation related to the merger, and (3) adjournment of the special meeting if needed.
Both boards unanimously recommend voting in favor of all proposals.
Special meetings for both companies are scheduled for August 25, 2026, and will be held virtually.
Board of directors and corporate governance
The combined company board will have 10 members: 4 from Olin, 4 from Huntsman, and the CEOs of both companies.
Kenneth T. Lane (Olin CEO) will serve as CEO of the combined company; Peter R. Huntsman (Huntsman CEO) will serve as non-executive Chair.
Board committees will have equal representation from both legacy companies, and a Strategic Integration Committee will oversee merger integration.
Latest events from Huntsman
- Q4 2024 saw revenue growth and improved EBITDA, but net loss and restructuring persist.HUN
Q4 20249 Jul 2026 - Revenue fell 5%, net loss narrowed, and a 65% dividend cut preserved cash amid restructuring.HUN
Q3 20258 Jul 2026 - Q2 2024 saw lower revenue and EBITDA, higher net income, and 9% sales volume growth.HUN
Q2 202430 Jun 2026 - $12B+ all-stock merger creates a chemicals leader with $400M+ synergies, closing H1 2027.HUN
M&A announcement16 Jun 2026 - $12B+ merger forms a chemicals leader with $400M+ synergies and balanced governance.HUN
Investor presentation16 Jun 2026 - Board elections, compensation, and auditor ratified; independent chair proposal rejected.HUN
AGM 202615 May 2026 - Net loss widened to $53M on flat revenue, with Advanced Materials outperforming other segments.HUN
Q1 20261 May 2026 - Board urges support for all director nominees, highlighting Mr. Muñoz’s strategic value despite attendance concerns.HUN
Proxy filing20 Apr 2026 - Annual meeting covers director elections, say-on-pay, auditor ratification, and governance proposal.HUN
Proxy Filing16 Mar 2026